Middle East & Africa Immunodiagnostics Market Forecast to 2030
Middle East & Africa Immunodiagnostics Market Forecast to 2030 – Regional Analysis – by Product (Enzyme-Linked Immunosorbent Assays (ELISA), Chemiluminescence Immunoassays (CLIA), Radioimmunoassays (RIA), and Others), Clinical Indication (Infectious Diseases, Hepatitis+HIV, Endocrinology, Gastrointestinal, Metabolics, and Others), and End User (Hospitals, Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others)
$2,100 – $3,500
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Rising Focus on R&D Investment and Expansion by Key Players Drives Middle East & Africa Industrial Robotics Market
Research and development (R&D) have been the crucial part of the pharmaceutical business. It enables companies to develop new products with significant medical and commercial potential for various diagnostic applications. Due to the surging prevalence of infectious diseases, companies invest and generate huge revenues for expansion activities. During the COVID-19 pandemic, Thermo Fisher Scientific Inc. witnessed a 48% increase in the sales of its specialty diagnostics segment (sub-segmented into clinical diagnostics, immunodiagnostics, microbiology, transplant diagnostics, and healthcare market channel) in 2020. The segmental revenue of the company further increased in 2021 due to higher demand and sales of immunodiagnostics products used in COVID-19 treatment. Siemens Healthineers announced the investment of over US$ 32 million in its Glasgow Laboratory Diagnostics Manufacturing Facility in Newark, Delaware, in September 2021. The investment extending over 24 months, enabled the company to add over 20 diagnostic tests in Delaware manufacturing capabilities. This initiative boosted the productivity of companies by maintaining stability across their diagnostic supply chains.
The extensive R&D for introducing innovative products opens several opportunities for small players and start-ups.
Manufacturers have also made a few key investments in the last few years. Cisco Systems, a global technology leader, invested US$ 225 million to combat the COVID-19 pandemic. This enabled the company to expand significantly and encourage new players to enter the market.
Middle East & Africa Immunodiagnostics Market Overview
In Saudi Arabia, hypertension, diabetes, obesity, heart diseases, and asthma are reported as common chronic diseases. These chronic diseases can be well monitored with the use of in-vitro diagnostics. According to the November 2021 report of the World Bank on the prevalence of noncommunicable diseases in Saudi Arabia, 185,500 new cases of cardiovascular disease, 303,500 new cases of chronic respiratory illness, and 2.1 million new cancer cases were recorded. Further, as per the 2021 report of the International Diabetes Federation (IDF), the burden of diabetes in Saudi Arabia is expected to increase from 4.3 million in 2021 to 7.5 million by 2045, and the demand for immunoassay products is likely to rise in the country, thus fueling the Middle East & Africa immunodiagnostics market in Saudi Arabia.
Similarly, increasing developments by the key market players are boosting market growth. For instance, in February 2020, Ortho Clinical Diagnostics launched the VITROS XT 3400 Chemistry System, which completes the company’s VITROS XT Solutions, a suite of solutions for clinical diagnostics laboratories to obtain consistently fast, accurate, and reliable results. The VITROS XT 3400 is available in several countries in the Middle East, including Saudi Arabia. Thus, such product launches are expected to increase market growth.
According to the data published by Globocan in 2020, cancer incidence was 27,885, whereas the five-year prevalence was 82,640 in Saudi Arabia. Colorectum, breast, thyroid, non-Hodgkin lymphoma, and leukemia were the most common cancer types in the country. The high burden of cancer cases will likely raise the demand for immunodiagnostics, influencing the market’s growth during the forecast period.
Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Middle East & Africa Immunodiagnostics Market Segmentation
The Middle East & Africa immunodiagnostics market is segmented into product, clinical indication, end user, and country.
Based on product, the Middle East & Africa immunodiagnostics market is segmented into enzyme-linked immunosorbent assays (ELISA), chemiluminescence immunoassays (CLIA), radioimmunoassays (RIA), and others. In 2023, the enzyme-linked immunosorbent assays (ELISA) segment registered the largest share in the Middle East & Africa immunodiagnostics market. The chemiluminescence immunoassays (CLIA) segment is further segmented into vitamin D assay market, HIV detection market, HIV ag/ab combo assay market, and other tests.
Based on clinical indication, the Middle East & Africa immunodiagnostics market is segmented into infectious diseases, hepatitis+HIV, endocrinology, gastrointestinal, metabolics, and others. In 2023, the infectious diseases segment registered the largest share in the Middle East & Africa immunodiagnostics market. The infectious diseases segment is further segmented into COVID-19, tuberculosis, lyme, infection management, zika, treponema, torch, measles and mumps, VZV, and EBV. The endocrinology segment is further segmented into hypertension, growth, diabetes, thyroid, and reproductive endocrinology.
Based on end user, the Middle East & Africa immunodiagnostics market is segmented into hospitals, clinics, diagnostic laboratories, academic & research institutes, and others. In 2023, the hospitals segment registered the largest share in the Middle East & Africa immunodiagnostics market.
Based on country, the Middle East & Africa immunodiagnostics market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. In 2023, Saudi Arabia registered the largest share in the Middle East & Africa immunodiagnostics market.
Abbott Laboratories; bioMerieux SA; Danaher Corp; DiaSorin SpA; F. Hoffmann-La Roche Ltd; PerkinElmer Inc; Shenzhen Mindray Bio-Medical Electronics Co., Ltd.; Siemens Healthcare GmbH; Svar Life Science AB; and Thermo Fisher Scientific Inc are some of the leading companies operating in the Middle East & Africa immunodiagnostics market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to the research team Market research, the Middle East & Africa immunodiagnostics market was valued at US$ 636.46 million in 2023 and is expected to reach US$ 1,089.81 million by 2030, registering a CAGR of 8.0% from 2023 to 2030. Technological advancements in immunodiagnostics and rising focus on R&D investment and expansion by key players are the critical factors attributed to the Middle East & Africa immunodiagnostics market expansion.
The current trend in immunodiagnostics is microfluidics and magnetic beads with potential commercialization. These sensitive, specific, and time-saving methodologies are essential in understanding and diagnosing health conditions, such as infectious diseases, metabolic disorders, and cardiac problems.
The increasing applications of immunodiagnostics solutions encouraged the development of targeted treatments and therapies for precision health. The prominent market players also promote assay technologies, microfluidics, and magnetic beads. For immunoassays, magnetic particles, such as Sera-Mag beads, offer a convenient alternative to plate-based ELISAs, as both rely on the same assay principle. Merck KGaA launched the Magna Chip Protein A magnetic beads. This recombinant Protein A is covalently bound to magnetic beads for chromatin immunoprecipitations (Chip assays), providing users with a faster, reproducible, and more efficient reagent for collecting immunocomplexes than agarose beads.
In microfluidics, some immunodiagnostics target single biomarkers. However, a recent trend shows the detection of multiple analytes according to the complexity and the need to make early reliable diagnoses.
In September 2023, Siemens Healthineers released its new CE-marked SARS-CoV-2/FluA/FluB/HRSV assay, a PCR test, and the CLINITEST Rapid COVID-19 + Influenza Antigen Test. The new FTD SARS-CoV-2/FluA/FluB/HRSV assay enables comprehensive and semi-automated molecular testing for seasonal respiratory pathogens. The combination PCR test detects and differentiates clinically relevant viruses such as SARS-CoV-2, Influenza A, Influenza B, and HRSV A/B.
On the contrary, inadequate reimbursement scenario hurdles the growth of Middle East & Africa immunodiagnostics market.
Based on product, the Middle East & Africa immunodiagnostics market is segmented into enzyme-linked immunosorbent assays (ELISA), chemiluminescence immunoassays (CLIA), radioimmunoassays (RIA), and others. The enzyme-linked immunosorbent assays (ELISA) segment held 55.1% share of Middle East & Africa immunodiagnostics market in 2023, amassing US$ 350.43 million. It is projected to garner US$ 594.51 million by 2030 to expand at 7.8% CAGR during 2023–2030. The chemiluminescence immunoassays (CLIA) segment is further segmented into vitamin D assay market, HIV detection market, HIV ag/ab combo assay market, and other tests.
Based on clinical indication, the Middle East & Africa immunodiagnostics market is segmented into infectious diseases, hepatitis+HIV, endocrinology, gastrointestinal, metabolics, and others. The infectious diseases segment held 45.2% share of Middle East & Africa immunodiagnostics market in 2023, amassing US$ 287.97 million. It is projected to garner US$ 511.44 million by 2030 to expand at 8.6% CAGR during 2023–2030. The infectious diseases segment is further segmented into COVID-19, tuberculosis, lyme, infection management, zika, treponema, torch, measles and mumps, VZV, and EBV. The endocrinology segment is further segmented into hypertension, growth, diabetes, thyroid, and reproductive endocrinology.
Based on end user, the Middle East & Africa immunodiagnostics market is segmented into hospitals, clinics, diagnostic laboratories, academic & research institutes, and others. The hospitals segment held 43.2% share of Middle East & Africa immunodiagnostics market in 2023, amassing US$ 275.03 million. It is projected to garner US$ 460.80 million by 2030 to expand at 7.7% CAGR during 2023–2030.
Based on country, the Middle East & Africa immunodiagnostics market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Our regional analysis states that Saudi Arabia captured 33.9% share of Middle East & Africa immunodiagnostics market in 2023. It was assessed at US$ 215.44 million in 2023 and is likely to hit US$ 361.27 million by 2030, exhibiting a CAGR of 7.7% during 2023–2030.
Key players operating in the Middle East & Africa immunodiagnostics market are Abbott Laboratories; bioMerieux SA; Danaher Corp; DiaSorin SpA; F. Hoffmann-La Roche Ltd; PerkinElmer Inc; Shenzhen Mindray Bio-Medical Electronics Co., Ltd.; Siemens Healthcare GmbH; Svar Life Science AB; and Thermo Fisher Scientific Inc, among others.
o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa immunodiagnostics market.
o Highlights key business priorities in order to assist companies to realign their business strategies
o The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa immunodiagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
o Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the immunodiagnostics market, as well as those hindering it
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Research Team Report Guidance
1.3 Market Segmentation
1.3.1 Middle East & Africa Immunodiagnostics Market – by Product
1.3.2 Middle East & Africa Immunodiagnostics Market – by Clinical Indication
1.3.3 Middle East & Africa Immunodiagnostics Market – by End User
1.3.4 Middle East & Africa Immunodiagnostics Market – by Country
2. Middle East & Africa Immunodiagnostics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Immunodiagnostics Market – Market Landscape
4.1 Overview
4.2 Middle East & Africa PEST Analysis
4.3 Expert’s Opinion
5. Middle East & Africa Immunodiagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Infectious Diseases
5.1.2 Growing Use of Point-of-Care Immunodiagnostics
5.2 Market Restraints
5.2.1 Inadequate Reimbursement Scenario
5.3 Market Opportunities
5.3.1 Rising Focus on R&D Investment and Expansion by Key Players
5.4 Future Trends
5.4.1 Technological Advancements in Immunodiagnostics
5.5 Impact Analysis
6. Immunodiagnostics Market – Middle East & Africa Analysis
6.1 Middle East & Africa Immunodiagnostics Market Revenue Forecast and Analysis
7. Middle East & Africa Immunodiagnostics Market Analysis – by Product
7.1 Overview
7.2 Middle East & Africa Immunodiagnostics Market, By Product, 2022 & 2030 (%)
7.3 Enzyme-linked Immunosorbent Assays (ELISA)
7.3.1 Overview
7.3.2 Enzyme-linked Immunosorbent Assays (ELISA): Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.4 Chemiluminescence Immunoassays (CLIA)
7.4.1 Overview
7.4.2 Chemiluminescence Immunoassays (CLIA): Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.4.3 Vitamin D Assay
7.4.3.1 Overview
7.4.3.2 Vitamin D Assay: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.4.4 HIV Detection
7.4.4.1 Overview
7.4.4.2 HIV Detection: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.4.5 HIV Ag/Ab Combo assay
7.4.5.1 Overview
7.4.5.2 HIV Ag/Ab Combo Assay: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.4.6 Other Tests
7.4.6.1 Overview
7.4.6.2 Other Tests: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.5 Radioimmunoassays (RIA)
7.5.1 Overview
7.5.2 Radioimmunoassays (RIA): Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Immunodiagnostics Market Analysis – Clinical Indication
8.1 Overview
8.2 Middle East & Africa Immunodiagnostics Market Share by Clinical Indication – 2022 & 2030 (%)
8.3 Infectious Diseases:
8.3.1 Overview
8.3.2 Infectious Diseases: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.1 COVID-19
8.3.2.1.1 Overview
8.3.2.1.2 COVID-19: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.2 Tuberculosis
8.3.2.2.1 Overview
8.3.2.2.2 Tuberculosis: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.3 Lyme
8.3.2.3.1 Overview
8.3.2.3.2 Lyme: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.4 Infection Management
8.3.2.4.1 Overview
8.3.2.4.2 Infection Management: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.5 Zika
8.3.2.5.1 Overview
8.3.2.5.2 Zika: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.6 Treponema
8.3.2.6.1 Overview
8.3.2.6.2 Treponema: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.7 TORCH
8.3.2.7.1 Overview
8.3.2.7.2 TORCH: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.8 Measles and Mumps
8.3.2.8.1 Overview
8.3.2.8.2 Measles and Mumps: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.9 VZV
8.3.2.9.1 Overview
8.3.2.9.2 VZV: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.10 EBV
8.3.2.10.1 Overview
8.3.2.10.2 EBV: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.4 Hepatitis+HIV:
8.4.1 Overview
8.4.2 Hepatitis+HIV: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.5 Gastrointestinal
8.5.1 Overview
8.5.2 Gastrointestinal: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.6 Metabolic Disorders
8.6.1 Overview
8.6.2 Metabolics: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7 Endocrinology
8.7.1 Overview
8.7.2 Endocrinology: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7.3 Hypertension
8.7.3.1 Overview
8.7.3.2 Hypertension: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7.4 Growth
8.7.4.1 Overview
8.7.4.2 Growth: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7.5 Diabetes
8.7.5.1 Overview
8.7.5.2 Diabetes: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7.6 Thyroid
8.7.6.1 Overview
8.7.6.2 Thyroid: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7.7 Reproductive Endocrinology
8.7.7.1 Overview
8.7.7.2 Reproductive Endocrinology: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa Immunodiagnostics Market Analysis – End User
9.1 Overview
9.2 Middle East & Africa Immunodiagnostics Market Share by End User – 2022 & 2030 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.4 Clinics
9.4.1 Overview
9.4.2 Clinics: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.5 Diagnostic Laboratories
9.5.1 Overview
9.5.2 Diagnostic Laboratories: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.6 Academic and Research Institutes
9.6.1 Overview
9.6.2 Academic and Research Institutes: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
10. Middle East & Africa Immunodiagnostics Market – Revenue and Forecast to 2030 – Country Analysis
10.1 Overview
10.1.1.1 UAE: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 UAE: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.3 UAE: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.1.1.1.3.1 UAE: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.4 UAE: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.4.1 UAE: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.4.2 UAE: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.5 UAE: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.1.1.2 Saudi Arabia: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Saudi Arabia: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 Saudi Arabia: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.1.1.2.3.1 Saudi Arabia: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.4 Saudi Arabia: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.4.1 Saudi Arabia: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.4.2 Saudi Arabia: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.5 Saudi Arabia: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.1.1.3 South Africa: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 South Africa: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 South Africa: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.1.1.3.3.1 South Africa: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.4 South Africa: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.4.1 South Africa: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.4.2 South Africa: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.5 South Africa: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.1.1.4 Rest of Middle East & Africa: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Rest of Middle East & Africa: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.3 Rest of Middle East & Africa: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.1.1.4.3.1 Rest of Middle East & Africa: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.4 Rest of Middle East & Africa: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.4.1 Rest of Middle East & Africa: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.4.2 Rest of Middle East & Africa: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.5 Rest of Middle East & Africa: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
11. Middle East & Africa Immunodiagnostics Market –Industry Landscape
11.1 Overview
11.2 Inorganic Growth Strategies
11.2.1 Overview
11.3 Organic Growth Strategies
11.3.1 Overview
12. Company Profiles
12.1 Abbott Laboratories
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 F. Hoffmann-La Roche Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 DiaSorin SpA
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Danaher Corp
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Thermo Fisher Scientific Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 PerkinElmer Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 bioMerieux SA
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Svar Life Science AB
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Siemens Healthcare GmbH
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. UAE Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 2. UAE Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 3. UAE Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 4. UAE Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 5. UAE Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 6. UAE Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 7. Saudi Arabia Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 8. Saudi Arabia Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 9. Saudi Arabia Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 10. Saudi Arabia: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 11. Saudi Arabia Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 12. Saudi Arabia Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 13. South Africa Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 14. South Africa Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 15. South Africa Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 16. South Africa: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 17. South Africa Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 18. South Africa Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 19. Rest of Middle East & Africa Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 20. Rest of Middle East & Africa Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 21. Rest of Middle East & Africa Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 22. Rest of Middle East & Africa: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 23. Rest of Middle East & Africa Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 24. Rest of Middle East & Africa Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 25. Recent Inorganic Growth Strategies in the Middle East & Africa immunodiagnostics market
Table 26. Recent Organic Growth Strategies in the Middle East & Africa immunodiagnostics market
Table 27. Glossary of Terms, Middle East & Africa Immunodiagnostics Market
LIST OF FIGURES
Figure 1. Middle East & Africa Immunodiagnostics Market Segmentation
Figure 2. Middle East & Africa Immunodiagnostics Market, by Country
Figure 3. Middle East & Africa Immunodiagnostics Market Overview
Figure 4. Enzyme-Linked Immunosorbent Assays (ELISA) Segment Held Largest Share of Product Segment in Middle East & Africa Immunodiagnostics Market
Figure 5. UAE Expected to Show Remarkable Growth During Forecast Period
Figure 6. Middle East & Africa: PEST Analysis
Figure 7. Experts’ Opinion
Figure 8. Middle East & Africa Immunodiagnostics Market: Impact Analysis of Drivers and Restraints
Figure 9. Middle East & Africa Immunodiagnostics Market – Revenue Forecast and Analysis – 2021–2030
Figure 10. Middle East & Africa Immunodiagnostics Market, by Product, 2022 & 2030 (%)
Figure 11. Enzyme-linked Immunosorbent Assays (ELISA): Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 12. Chemiluminescence Immunoassays (CLIA): Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 13. Vitamin D Assay: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 14. HIV Detection: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 15. HIV Ag/Ab Combo Assay: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 16. Other Tests: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 17. Radioimmunoassays (RIA): Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 18. Others: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 19. Middle East & Africa Immunodiagnostics Market Share by Clinical Indication – 2022 & 2030 (%)
Figure 20. Infectious Diseases: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 21. COVID-19: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 22. Tuberculosis: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 23. Lyme: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 24. Infection Management: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 25. Zika: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 26. Treponema: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 27. TORCH: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 28. Measles and Mumps: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 29. VZV: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 30. EBV: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 31. Hepatitis+HIV: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 32. Gastrointestinal: Middle East & Africa Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 33. Metabolics: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 34. Endocrinology: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 35. Hypertension: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 36. Growth: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 37. Diabetes: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 38. Thyroid: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 39. Reproductive Endocrinology: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 40. Endocrinology: Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 41. Middle East & Africa Immunodiagnostics Market Share by End User – 2022 & 2030 (%)
Figure 42. Hospitals: Middle East & Africa Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 43. Clinics: Middle East & Africa Immunodiagnostics Market Revenue and Forecasts To 2030 (US$ Million)
Figure 44. Diagnostic Laboratories: Middle East & Africa Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 45. Academic and Research Institutes: Middle East & Africa Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 46. Others: Middle East & Africa Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 47. Middle East & Africa Immunodiagnostics Market, by Key Country – Revenue (2022) (US$ Million)
Figure 48. Middle East & Africa: Immunodiagnostics Market, by Country, 2022 & 2030 (%)
Figure 49. UAE: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 50. Saudi Arabia: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 51. South Africa: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 52. Rest of Middle East & Africa: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
The List of Companies – Middle East & Africa Immunodiagnostics Market
o Abbott Laboratories
o bioMerieux SA
o Danaher Corp
o DiaSorin SpA
o F. Hoffmann-La Roche Ltd
o PerkinElmer Inc
o Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
o Siemens Healthcare GmbH
o Svar Life Science AB
o Thermo Fisher Scientific Inc
You must be logged in to post a review.
Reviews
There are no reviews yet.